2012-10-06 19:12:01 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Urea Cycle Disorders - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Urea Cycle Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Urea Cycle Disorders. Urea Cycle Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of

data for the indicated disease.


Full Report Details at
- www.fastmr.com/prod/468475_urea_cycle_disorders_pipeline_review_ ..


Scope

* A snapshot of the global therapeutic scenario for Urea Cycle Disorders.
* A review of the Urea Cycle Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Urea Cycle Disorders pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Urea Cycle Disorders.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Urea Cycle Disorders pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Urea Cycle Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Urea Cycle Disorders
Urea Cycle Disorders Therapeutics under Development by Companies
Urea Cycle Disorders Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Urea Cycle Disorders Therapeutics - Products under Development by Companies
Urea Cycle Disorders Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Urea Cycle Disorders Therapeutics Development
Aspen Pharmacare Holdings Ltd
Ocera Therapeutics, Inc.
Hyperion Therapeutic, Inc.
Promethera Biosciences
Urea Cycle Disorders - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
glycerol phenylbutyrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ornithine phenylacetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
carglumic acid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Human Heterologous Liver Cells - Drug Profile
Product Description
Mechanism of Action
R&D Progress
carglumic acid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Promethera HepaStem - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Urea Cycle Disorders Therapeutics - Drug Profile Updates
Urea Cycle Disorders - Product Development Milestones
Featured News & Press Releases
May 14, 2012: Promethera Biosciences Treats First Patients With Promethera HepaStem
Oct 19, 2011: Cytonet's Liver Cell Therapy Trial For Children With UCD Expands To Canada
May 17, 2011: Cytonet's Liver Cell Therapy Receives Orphan Drug Designation From FDA
Apr 13, 2011: Cytonet Launches Phase II Trial For Hereditary Urea Cycle Disorders (UCD) In Children
Nov 02, 2010: Hyperion' Glycerol Phenylbutyrate Meets Primary Endpoint In Phase III Pivotal Study In Urea Cycle Disorders
Oct 18, 2010: Hyperion Receives FDA Fast Track Designation For Glycerol Phenylbutyrate For Treatment Of Urea Cycle Disorders
Nov 02, 2009: UCL (University College London) Liver Failure Group Present Two Studies On A Novel Treatment Option (OCR-002) For Complications Of Hyperammonemia In Liver Failure At The 60th Annual AASLD Meeting
Feb 18, 2005: Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Urea Cycle Disorders, H2 2012
Products under Development for Urea Cycle Disorders - Comparative Analysis, H2 2012
Number of Products under Development by Companies, H2 2012
Number of Products under Investigation by Universities/Institutes, H2 2012
Comparative Analysis by Late Stage Development, H2 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468475&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.